Dihexa (10mg) / Tesofensine (250mcg) / BPC-157 (125mcg) Tri-Compound Oral Research Formulation x 60 Tablets

$349.00

SKU: PP-DIH-TESO-BPC-10-25-125×60 Categories: Neuropeptide Research Compounds, Oral Research Formulations, Peptide Blends, Small Molecule, Tesofensine Tags: General, GH Secretagogue Research, Metabolic Pathway Peptides, Neuropeptide Research, NEW, oral, pos, Tissue Modeling Research

Description
Additional information

Dihexa (10mg) / Tesofensine (250mcg) / BPC-157 (125mcg) Tri-Compound Oral Research Formulation x 60 Tablets

Oral solid-form research compound formulated for controlled analytical and investigational applications. Not intended for human or animal consumption.

Product Specifications
CAS Number(s)	BPC-157: 137525-51-0 Dihexa: 1401708-83-5 Tesofensine: 402856-42-2 (also 195875-84-4 free base)
Molecular Formula(s)	BPC-157: C62H98N16O22 Dihexa: C27H44N4O5 Tesofensine: C17H23Cl2NO
Molecular Weight(s) (g/mol)	BPC-157: 1419.55 Dihexa: 504.66 Tesofensine: 328.28
Compound Class / Type	BLEND (3 components)
Purity	Active ingredient ≥98% \| COA available
Physical Form	Compressed oral tablet
Storage Conditions	Store at room temperature (15-25°C); keep dry; protect from light

For Research Use Only. Not for human or animal consumption.

Oral solid-form research compound formulated for controlled analytical and investigational applications. This product is not a drug, dietary supplement, or food product as defined under the Federal Food, Drug, and Cosmetic Act. It has not been evaluated or approved by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, mitigate, or prevent any disease and is not intended for ingestion by humans or animals.